Avadel Pharmaceuticals PLC (AVDL)
17.83
+0.01
(+0.06%)
USD |
NASDAQ |
Apr 26, 16:00
17.83
0.00 (0.00%)
After-Hours: 17:11
Avadel Pharmaceuticals Cash from Operations (TTM): -128.51M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -128.51M |
September 30, 2023 | -115.85M |
June 30, 2023 | -84.42M |
March 31, 2023 | -66.49M |
December 31, 2022 | -70.30M |
September 30, 2022 | -77.44M |
June 30, 2022 | -91.88M |
March 31, 2022 | -87.94M |
December 31, 2021 | -77.31M |
September 30, 2021 | -73.93M |
June 30, 2021 | -62.88M |
March 31, 2021 | -60.51M |
December 31, 2020 | -48.73M |
September 30, 2020 | -37.86M |
June 30, 2020 | -35.09M |
March 31, 2020 | -28.76M |
December 31, 2019 | -38.32M |
September 30, 2019 | -54.60M |
June 30, 2019 | -67.43M |
March 31, 2019 | -85.91M |
December 31, 2018 | -82.72M |
September 30, 2018 | -72.01M |
June 30, 2018 | -54.82M |
March 31, 2018 | -26.65M |
December 31, 2017 | 16.66M |
Date | Value |
---|---|
September 30, 2017 | 38.22M |
June 30, 2017 | 36.52M |
March 31, 2017 | 23.84M |
December 31, 2016 | 18.90M |
September 30, 2016 | 37.56M |
June 30, 2016 | 60.91M |
March 31, 2016 | 79.39M |
December 31, 2015 | 84.29M |
September 30, 2015 | 51.58M |
June 30, 2015 | 36.49M |
March 31, 2015 | 17.06M |
December 31, 2014 | -10.62M |
September 30, 2014 | -11.32M |
June 30, 2014 | -15.02M |
March 31, 2014 | -15.48M |
December 31, 2013 | -20.68M |
September 30, 2013 | -19.88M |
June 30, 2013 | -25.33M |
March 31, 2013 | -26.15M |
December 31, 2012 | -23.14M |
September 30, 2012 | -20.64M |
June 30, 2012 | -16.82M |
March 31, 2012 | -10.58M |
December 31, 2011 | -10.32M |
September 30, 2011 | -6.614M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-128.51M
Minimum
Dec 2023
-28.76M
Maximum
Mar 2020
-68.86M
Average
-67.43M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
Trinity Biotech PLC | -9.968M |
Medtronic PLC | 6.47B |
Biophytis SA | -13.97M |
Jazz Pharmaceuticals PLC | 1.092B |
DBV Technologies SA | -79.65M |